|
2
|
16
|
1pmxB |
Insulin-like growth factor-i bound to a phage-derived peptide |
|
30
|
136
|
1pwaA |
Crystal structure of fibroblast growth factor 19 |
|
36
|
141
|
1q04A |
Crystal structure of fgf-1, s50e/v51n |
|
3
|
21
|
1q4vA |
Crystal structure of allo-ilea2-insulin, an inactive chiral analogue: implications for the mechanism of receptor |
|
96
|
308
|
1p4oA |
Structure of apo unactivated igf-1r kinase domain at 1.5a resolution. |
|
6
|
29
|
1os3B |
Dehydrated t6 human insulin at 100 k |
|
5
|
29
|
1os4B |
Dehydrated t6 human insulin at 295 k |
|
5
|
21
|
1os3A |
Dehydrated t6 human insulin at 100 k |
|
5
|
21
|
1os4A |
Dehydrated t6 human insulin at 295 k |
|
37
|
140
|
1p63A |
Human acidic fibroblast growth factor. 140 amino acid form with amino terminal his tag and leu111 replaced with ile (l111i) |
|
4
|
54
|
1p9jA |
Solution structure and dynamics of the egf/tgf-alpha chimera t1e |
|
35
|
141
|
1nzkA |
Crystal structure of a multiple mutant (l44f, l73v, v109l, l111i, c117v) of human acidic fibroblast growth factor |
|
9
|
27
|
1nauA |
Nmr solution structure of the glucagon antagonist [deshis1, desphe6, glu9]glucagon amide in the presence of perdeuterated dodecylphosphocholine micelles |
|
32
|
172
|
1nk1A |
Nk1 fragment of human hepatocyte growth factor/scatter factor (hgf/sf) at 2.5 angstrom resolution |
|
14
|
94
|
1mkgA |
Disulfide deficient mutant of vascular endothelial growth factor a (c57a and c102a) |
|
98
|
244
|
1n4hA |
Characterization of ligands for the orphan nuclear receptor rorbeta |
|
15
|
93
|
1mkkA |
Disulfide deficient mutant of vascular endothelial growth factor a (c61a and c104a) |
|
19
|
96
|
1mjvA |
Disulfide deficient mutant of vascular endothelial growth factor a (c51a and c60a) |
|
5
|
21
|
1msoA |
T6 human insulin at 1.0 a resolution |
|
3
|
10
|
1n4hB |
Characterization of ligands for the orphan nuclear receptor rorbeta |
|
13
|
96
|
1n27A |
Solution structure of the pwwp domain of mouse hepatoma-derived growth factor, related protein 3 |
|
6
|
30
|
1msoB |
T6 human insulin at 1.0 a resolution |
|
15
|
104
|
1lxiA |
Refinement of bmp7 crystal structure |
|
5
|
21
|
1m5aA |
Crystal structure of 2-co(2+)-insulin at 1.2a resolution |
|
13
|
73
|
1lr7A |
Crystal structure of fs1, the heparin-binding domain of follistatin, complexed with the heparin analogue sucrose octasulphate (sos) |
|
13
|
73
|
1lr8A |
Crystal structure of fs1, the heparin-binding domain of follistatin, complexed with the heparin analogue d-myo-inositol hexasulphate (ins6s) |
|
11
|
73
|
1lr9A |
Structure of fs1, the heparin-binding domain of follistatin |
|
3
|
30
|
1lkqB |
Nmr structure of human insulin mutant ile-a2-gly, val-a3-gly, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures |
|
24
|
105
|
1m9zA |
Crystal structure of human tgf-beta type ii receptor ligand binding domain |
|
17
|
112
|
1m4uL |
Crystal structure of bone morphogenetic protein-7 (bmp-7) in complex with the secreted antagonist noggin |
|
7
|
36
|
1ljvA |
Bovine pancreatic polypeptide bound to dpc micelles |
|
4
|
21
|
1lkqA |
Nmr structure of human insulin mutant ile-a2-gly, val-a3-gly, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures |
|
8
|
22
|
1lbjA |
Nmr solution structure of motilin in phospholipid bicellar solution |
|
5
|
30
|
1m5aB |
Crystal structure of 2-co(2+)-insulin at 1.2a resolution |
|
35
|
206
|
1m4uA |
Crystal structure of bone morphogenetic protein-7 (bmp-7) in complex with the secreted antagonist noggin |
|
35
|
142
|
1m16A |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag and leu 44 replaced with phe (l44f), leu 73 replaced with val (l73v), val 109 replaced with leu (v109l) and cys 117 replaced with val (c117v). |
|
15
|
92
|
1l5dA |
Solution structure of the monomeric form of a mutant unliganded bovine neurophysin, minimized average structure |
|
39
|
204
|
1kf9B |
Phage display derived variant of human growth hormone complexed with two copies of the extracellular domain of its receptor |
|
52
|
190
|
1kf9A |
Phage display derived variant of human growth hormone complexed with two copies of the extracellular domain of its receptor |
|
2
|
37
|
1ju8A |
Solution structure of leginsulin, a plant hormon |
|
37
|
141
|
1jt4A |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag and val 109 replaced by leu (v109l) |
|
97
|
244
|
1k4wA |
X-ray structure of the orphan nuclear receptor ror beta ligand-binding domain in the active conformation |
|
31
|
129
|
1k5uA |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag with his93 replaced by gly (h93g). |
|
36
|
128
|
1k5vA |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag with asn106 replaced by gly (n106g). |
|
38
|
141
|
1jqzA |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag. |
|
2
|
46
|
1k37A |
Nmr structure of human epiregulin |
|
36
|
140
|
1jy0A |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag and cys 117 replaced with val (c117v). |
|
38
|
143
|
1jt3A |
Human acidic fibroblast growth factor. 141 amino acid form with amino histidine tag and leu 73 replaced by val (l73v) |
|
36
|
142
|
1jt5A |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag and leu 73 replaced by val and val 109 replaced by leu (l73v/v109l) |
|
36
|
141
|
1jtcA |
Human acidic fibroblast growth factor. 141 amino acid form with amino terminal his tag and leu 44 replaced by phe (l44f) |
